COST-EFFECTIVENESS OF NIVOLUMAB plus IPILIMUMAB IN FIRST-LINE TREATMENT OF UNRESECTABLE MALIGNANT PLEURAL MESOTHELIOMA (UMPM) IN THE NETHERLANDSM. J. Daumont, E. Torkilseng, M. Pompen, J. Stevanovic, E. StawowczykVALUE IN HEALTH（2022）引用 0|浏览2暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
